FibroBiologics, Inc.
FBLGNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $6.27M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.22$9.60
- Volume (live)
- -
- Avg. volume (3M)
- 139.35K
FibroBiologics (FBLG) Stock Price & Financial Analysis
FibroBiologics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.95 - $1.04 |
|---|---|
| 52-Week High | $9.60 |
| 52-Week Low | $0.22 |
| Open | $1.02 |
| Volume (last close) | 35.97K |
| Average Volume (3M) | 139.35K |
| 50-Day MA | $1.33 |
|---|---|
| 200-Day MA | $2.65 |
| 1-Year Change | +149.50% |
| Market Cap | 6.27M |
|---|---|
| Shares Outstanding | 6.27M |
| Price to Book (P/B) | 1.35 |
| EV/EBITDA | -0.23 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
FibroBiologics at a Glance
As of the Oct 16, 2026 close, FibroBiologics (FBLG) has a market capitalization of $6.27M.
As of its latest reported balance sheet, it holds $3.52M in cash and securities against $1.20M of debt, a net cash position of $2.31M.
FibroBiologics does not currently pay a dividend.
The share price is up 149.5% over the past year. At $0.96 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.22 to $9.60, below its 200-day moving average of $2.65.
Frequently Asked Questions About FibroBiologics
What is the current stock price for FBLG?
As of the Oct 16, 2026 close, FBLG stock trades at $0.96. The 52-week range is $0.22–$9.60, with a day range of $0.95–$1.04.
What is the P/E ratio for FBLG?
The P/E ratio (Price-to-Earnings) for FBLG is shown in the Key Statistics section. This valuation metric helps compare FibroBiologics, Inc. to industry peers.
Does FBLG pay dividends?
FibroBiologics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for FBLG?
Analyst ratings and recommendations for FBLG are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of FBLG?
As of the Oct 16, 2026 close, FibroBiologics's market capitalization is $6.0M, classifying it as a micro-cap company. FibroBiologics operates in the Healthcare sector within the Biotechnology industry.